Product Information
SULFACETAMIDE-SULFUR 8-4% SUSP is a generic product labeled by Method Pharmaceuticals LLC, priced at $0.0710 per ML under NDC 58657046916. Its NADAC has been published 212 times since Sep 14, 2022.
Strength
80; 40 mg/mL; mg/mL
Manufacturer
Method Pharmaceuticals LLCNDC
58657046916
Classification
Generic
Dosage Form
LIQUID
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
SULFACETAMIDE SODIUM; SULFURApproval Type
Unapproved
On Market Since
2/1/2022
Pharmacological Classes
Price Statistics
The NADAC for SULFACETAMIDE-SULFUR 8-4% SUSP has been published 212 times since Sep 14, 2022, and over the history we have for it it has declined 42.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0710 per ML |
|---|---|
| All-time high | $0.1498 (Jul 12, 2023) |
| All-time low | $0.0612 (Apr 22, 2026) |
| 52-week high | $0.0814 |
| 52-week low | $0.0612 |
| Median price | $0.1009 |
| Average price | $0.1018 |
| Largest weekly change | -24.9% (Jul 17, 2024) |
| Weeks tracked | 212 |
| Tracking since | Sep 14, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the SULFACETAMIDE SODIUM, SULFUR market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Method Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
SULFACETAMIDE SODIUM, SULFUR market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sulfonamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SULFACETAMIDE-SULFUR 8-4% SUSP?
The current National Average Drug Acquisition Cost (NADAC) for SULFACETAMIDE-SULFUR 8-4% SUSP, manufactured by Method Pharmaceuticals LLC, is $0.0710 per ML (NDC 58657046916), effective Sep 30, 2026.
How has the price of SULFACETAMIDE-SULFUR 8-4% SUSP changed over time?
Over the history we have for it, the NADAC for SULFACETAMIDE-SULFUR 8-4% SUSP has declined 42.0%. It has been tracked across 212 weekly CMS publications since Sep 14, 2022.
What are the highest and lowest recorded NADAC prices for SULFACETAMIDE-SULFUR 8-4% SUSP?
Since Sep 14, 2022, the NADAC for SULFACETAMIDE-SULFUR 8-4% SUSP has ranged from a low of $0.0612 (Apr 22, 2026) to a high of $0.1498 (Jul 12, 2023), with a median of $0.1009 per ML.
Are there cheaper alternatives to SULFACETAMIDE-SULFUR 8-4% SUSP?
No other NADAC-published product currently shares the active ingredient and strength of SULFACETAMIDE-SULFUR 8-4% SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SULFACETAMIDE-SULFUR 8-4% SUSP?
SULFACETAMIDE-SULFUR 8-4% SUSP (NDC 58657046916) is labeled by Method Pharmaceuticals LLC, and CMS classifies it as a generic product.